Clinical Trial Update: Melanoma Vaccine With Peptides and Leuprolide [Phase 2]

View source ↗

Summary

Phase 2 trial update of a melanoma vaccine combining peptides with leuprolide has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• peptide vaccine with leuprolide

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-10-16